Evidence map›Paper›PMID 34157101›Full record

ArticleTranslational vision science & technology2021

Development and Comparison of Machine Learning Algorithms to Determine Visual Field Progression.

Osamah Saeedi, Michael V Boland, Loris D'Acunto, Ramya Swamy, Vikram Hegde, Surabhi Gupta, Amin Venjara, Joby Tsai, Jonathan S Myers, Sarah R Wellik and 5 more

Abstract read
In one paragraph

Article in Translational vision science & technology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Osamah SaeediUniversity of Maryland Department of Ophthalmology and Visual Sciences, Baltimore, MD, USA.
Michael V BolandMassachusetts Eye and Ear, Boston, MA, USA.
Loris D'AcuntoSan Francisco, CA, USA.
Ramya SwamyUniversity of Maryland Department of Ophthalmology and Visual Sciences, Baltimore, MD, USA.
Vikram HegdeSan Francisco, CA, USA.
Surabhi GuptaSan Francisco, CA, USA.
Amin VenjaraPrinceton, NJ, USA.
Joby TsaiUniversity of Maryland Department of Ophthalmology and Visual Sciences, Baltimore, MD, USA.
Jonathan S MyersWills Eye Hospital, Philadelphia, PA, USA.
Sarah R WellikBascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL, USA.
Gustavo DeMoraesColumbia University, New York, NY, USA.
Louis R PasqualeIcahn School of Medicine at Mount Sinai, Department of Ophthalmology, New York, NY, USA.
Lucy Q ShenMassachusetts Eye and Ear, Boston, MA, USA.
Yangjiani LiSchepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Tobias ElzeSchepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.

Funding

VISION RESEARCHP30EY003790 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Patricia Ann D'Amore · 1985 to 2026
$25.5M
Gene-Environment Interactions in GlaucomaR01EY015473 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI PASQUALE, LOUIS ROBERT · 2005 to 2021
$8.3M
Personalizing Glaucoma Diagnosis by Disease Specific Patterns and Individual Eye AnatomyR01EY030575 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI ELZE, TOBIAS · 2019 to 2023
$2.4M
Structural and Functional Progression of Glaucomatous Damage to the MaculaR01EY025253 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DE MORAES, CARLOS GUSTAVO · 2015 to 2017
$1.2M
Role of Capillary Flow and Autoregulation in Primary Open Angle GlaucomaK23EY025014 · NEI · UNIVERSITY OF MARYLAND BALTIMORE · PI SAEEDI, OSAMAH JAWAID · 2015 to 2019
$1.0M
A hybrid artificial intelligence framework for glaucoma monitoringR21EY030142 · NEI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI ELZE, TOBIAS, YOUSEFI, SIAMAK · 2019 to 2020
$499k
NEI NIH HHS K23 EY025014NEI NIH HHS P30 EY003790NEI NIH HHS R01 EY015473NEI NIH HHS R01 EY025253NEI NIH HHS R01 EY030575NEI NIH HHS R21 EY030142
6 · The paper itself

Abstract

Purpose: To develop and test machine learning classifiers (MLCs) for determining visual field progression. Methods: In total, 90,713 visual fields from 13,156 eyes were included. Six different progression algorithms (linear regression of mean deviation, linear regression of the visual field index, Advanced Glaucoma Intervention Study algorithm, Collaborative Initial Glaucoma Treatment Study algorithm, pointwise linear regression [PLR], and permutation of PLR) were applied to classify each eye as progressing or stable. Six MLCs were applied (logistic regression, random forest, extreme gradient boosting, support vector classifier, convolutional neural network, fully connected neural network) using a training and testing set. For MLC input, visual fields for a given eye were divided into the first and second half and each location averaged over time within each half. Each algorithm was tested for accuracy, sensitivity, positive predictive value, and class bias with a subset of visual fields labeled by a panel of three experts from 161 eyes. Results: MLCs had similar performance metrics as some of the conventional algorithms and ranged from 87% to 91% accurate with sensitivity ranging from 0.83 to 0.88 and specificity from 0.92 to 0.96. All conventional algorithms showed significant class bias, meaning each individual algorithm was more likely to grade uncertain cases as either progressing or stable (P ≤ 0.01). Conversely, all MLCs were balanced, meaning they were equally likely to grade uncertain cases as either progressing or stable (P ≥ 0.08). Conclusions: MLCs showed a moderate to high level of accuracy, sensitivity, and specificity and were more balanced than conventional algorithms. Translational Relevance: MLCs may help to determine visual field progression.

Indexed as

Visual FieldsVisual Field TestsAlgorithmsHumansMachine LearningVision Disorders

Identifiers

PMID34157101
PMCPMC8237084

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.